July 25th 2025
Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.
Reemergence of targeted photon therapy useful for NMSCs in outpatient setting
May 1st 2013Recent advances in radiation therapy for the treatment of nonmelanoma skin cancer (NMSC) have resulted in a resurgence of targeted photon therapy, a treatment modality particularly useful in an outpatient setting. In carefully selected patients and cases, radiation therapy can often be the treatment of choice for NMSCs, says a clinician who spoke at the annual meeting of the American Academy of Dermatology.
Reformulated drugs for actinic keratosis address issues with field therapy
May 1st 2013New topical agents such as ingenol mebutate (Picato, Leo Pharma), reformulations of standing local treatments as well as combination therapies are not only proving to be very useful in the clearance of actinic keratosis (AK), but they also help address the common issues regarding field therapy.
For some skin cancers, clinicians must consider less expensive options than Mohs surgery
April 1st 2013Although Mohs micrographic surgery represents the gold standard for treatment of many skin cancers, says an expert, healthcare reform dictates that dermatologists also consider less costly options when appropriate.
Staged excision techniques for lentigo maligna address challenges
April 1st 2013The many vagaries of lentigo maligna (LM) or melanoma in situ typically demand staged excision techniques for maximal margin control, according to an expert who spoke at the 71st annual American Academy of Dermatology conference.
Clinical research zeroes in on targeted therapies for skin cancers
March 18th 2013Continued research has led to new and exciting noninvasive therapies for basal cell carcinoma (BCC), lentigo maligna and malignant melanoma, offering some patients an alternative to surgery and/radiation treatment approaches.
Organ transplant recipients present unique challenges for skin cancer care
March 18th 2013The treatment and management of skin cancers in organ transplant recipients (OTR) is challenging. Recent breakthrough medications and combination treatment approaches have resulted in more effective therapeutic options for this patient population.